MediPal Holdings Corporation
MEPDF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $6,438 | $945,159 | $864,156 | $982,500 |
| % Growth | -99.3% | 9.4% | -12% | – |
| Cost of Goods Sold | $6,018 | $880,481 | $802,622 | $914,716 |
| Gross Profit | $421 | $64,678 | $61,534 | $67,784 |
| % Margin | 6.5% | 6.8% | 7.1% | 6.9% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $41,075 | $42,151 | $40,206 |
| SG&A Expenses | $346 | $47,267 | $47,898 | $46,194 |
| Sales & Mktg Exp. | $0 | $6,192 | $5,747 | $5,988 |
| Other Operating Expenses | $0 | $3,358 | $3,399 | $3,380 |
| Operating Expenses | $346 | $50,625 | $51,297 | $49,574 |
| Operating Income | $75 | $14,053 | $10,237 | $18,210 |
| % Margin | 1.2% | 1.5% | 1.2% | 1.9% |
| Other Income/Exp. Net | $68 | $4,612 | $553 | $7,958 |
| Pre-Tax Income | $143 | $18,665 | $10,790 | $26,168 |
| Tax Expense | $42 | $6,054 | $4,488 | $8,510 |
| Net Income | $85 | $9,586 | $4,041 | $14,511 |
| % Margin | 1.3% | 1% | 0.5% | 1.5% |
| EPS | 0.41 | 46.17 | 19.43 | 69.78 |
| % Growth | -99.1% | 137.6% | -72.2% | – |
| EPS Diluted | 0.41 | 46.17 | 19.43 | 69.78 |
| Weighted Avg Shares Out | 206 | 208 | 208 | 208 |
| Weighted Avg Shares Out Dil | 206 | 208 | 208 | 208 |
| Supplemental Information | – | – | – | – |
| Interest Income | $1 | $913 | $804 | $757 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $31 | $3,353 | $4,604 | $4,496 |
| EBITDA | $174 | $17,411 | $14,837 | $22,707 |
| % Margin | 2.7% | 1.8% | 1.7% | 2.3% |